Investigating aging and membrane-associated T cell receptor signaling in human CD

研究人类 CD 中的衰老和膜相关 T 细胞受体信号传导

基本信息

  • 批准号:
    7330276
  • 负责人:
  • 金额:
    $ 13.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-01 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Alterations in T cell immunity occur with aging, contributing to increased risk of infection and malignancy. T cells are activated as they recognize antigenic peptide presented by antigen-presenting cells (APCs) via T cell receptors (TCR). This TCR triggering induces a series of biochemical events called signal transduction in T cells which are essential for T cell functions. Of interest, age-associated alterations in TCR signal transduction have been reported in mice and humans, linking to impaired T cell functions. However, in most human studies unsorted total CD4+ or CD8+ T cells have been used although different CD4+ and CD8+ T cell subsets, such as na¿ve and memory cells, with distinct functions exist and the proportion of na¿ve and memory CD4+ and CD8+ T cells alters with aging. Recently, my lab measured expression of IL-7 receptor alpha chain (IL-7Ra, CD127) which dictates the response to IL-7, a cytokine critical for T cell homeostasis, on CD8+ T cells in young and elderly individuals. In this study, cells expressing IL-7Rahigh and low were found in memory CD8+ T cells. Surprisingly, the elderly (age=65) had expansion of IL-7Ralow memory CD8+ T cells compared to the young (age=40). IL-7Ralow memory CD8+ T cells poorly proliferated in response to TCR triggering, indicating a TCR signaling defect(s) in these cells and the potential role for IL-7Ra as a marker for identifying memory CD8+ T cells with impaired TCR responses. Of interest, IL-7Ralow memory CD8+ T cells nicely proliferate in response to a combination of TCR triggering and IL-15, a cytokine essential for memory CD8+ T cell maintenance. This suggests a role for IL-15 in recovering the impaired TCR signal transduction in IL-7Ralow memory CD8+ T cells. Understanding the mechanism(s) for these findings is important since memory CD8+ T cells are essential for host defense and IL-15 is considered as an adjuvant for cellular immunity. The proposed study will address these issues based on the hypothesis that expanded IL-7Ralow memory CD8+ T cells with aging have a defect(s) in TCR signal transduction which can be rescued by IL-15. This hypothesis will be investigated focusing on a group of TCR signaling molecules that are closely associated with T cell membrane using confocal microscopy and flow cytometry. Specifically, following two aims are planned. First, investigate whether and why IL-7Ralow memory CD8+ T cells that expand with aging have a defect(s) in TCR signal transduction. Plus, alteration(s) in TCR signal transduction of other CD8+ T cell subsets and the potential mechanisms for defective TCR signal transduction in the CD8+ T cell subsets will be studied by measuring cholesterol content of the cell membrane and glycosylation of T cell surface molecules that are known to affect TCR signal transduction with aging. Secondly, it will be determined how IL-15 rescues impaired TCR signal transduction in IL-7Ralow memory CD8+ T cells. The results of this study will provide essential information that leads to better protection against tumors and infections in the elderly by enhancing cellular immunity. The goal of the current proposal is to study how aging affects the molecules involved in transmitting stimulations from the outside to the inside (signal transduction) of CD8+ T cells through their receptors (T cell receptor). The results of this study will provide important information on enhancing immune responses in the aged populations, leading to improved protection against infections and tumors.
描述(由申请人提供):T细胞免疫力的改变随着年龄的增长而发生,导致感染和恶性肿瘤风险增加。当T细胞识别由抗原呈递细胞(APC)通过T细胞受体(TCR)呈递的抗原肽时,T细胞被激活。这种TCR触发诱导T细胞中称为信号转导的一系列生物化学事件,其对于T细胞功能是必需的。令人感兴趣的是,在小鼠和人类中已经报道了TCR信号转导中与年龄相关的改变,其与受损的T细胞功能有关。然而,在大多数人类研究中,使用了未分选的总CD 4+或CD 8 + T细胞,尽管存在具有不同功能的不同CD 4+和CD 8 + T细胞亚群,如幼稚和记忆细胞,并且幼稚和记忆CD 4+和CD 8 + T细胞的比例随着年龄的增长而改变。最近,我的实验室测量了IL-7受体α链(IL-7 Ra,CD 127)的表达,该链决定了对年轻和老年个体中CD 8 + T细胞上IL-7(一种对T细胞稳态至关重要的细胞因子)的反应。在这项研究中,在记忆性CD 8 + T细胞中发现表达IL-7 Ra高和低的细胞。令人惊讶的是,与年轻人(年龄=40)相比,老年人(年龄=65)具有IL-7 Ralow记忆CD 8 + T细胞的扩增。IL-7 Ra低记忆性CD 8 + T细胞响应于TCR触发而增殖不良,表明这些细胞中的TCR信号传导缺陷以及IL-7 Ra作为鉴定具有受损TCR应答的记忆性CD 8 + T细胞的标志物的潜在作用。令人感兴趣的是,IL-7 Ralow记忆性CD 8 + T细胞响应于TCR触发和IL-15(一种对记忆性CD 8 + T细胞维持必不可少的细胞因子)的组合而良好地增殖。这表明IL-15在恢复IL-7 Ralow记忆CD 8 + T细胞中受损的TCR信号转导中发挥作用。理解这些发现的机制是重要的,因为记忆CD 8 + T细胞对于宿主防御是必需的,并且IL-15被认为是细胞免疫的佐剂。所提出的研究将基于以下假设来解决这些问题:随着衰老而扩增的IL-7 Ralow记忆CD 8 + T细胞在TCR信号转导中具有缺陷,其可以被IL-15拯救。这一假设将研究集中在一组TCR信号分子,是密切相关的T细胞膜,使用共聚焦显微镜和流式细胞术。具体而言,计划实现以下两个目标。首先,研究随着衰老而扩增的IL-7 Ralow记忆性CD 8 + T细胞是否以及为什么在TCR信号转导中存在缺陷。此外,通过测量细胞膜的胆固醇含量和已知随着衰老影响TCR信号转导的T细胞表面分子的糖基化,将研究其他CD 8 + T细胞亚群的TCR信号转导的改变和CD 8 + T细胞亚群中缺陷TCR信号转导的潜在机制。其次,将确定IL-15如何拯救IL-7低记忆性CD 8 + T细胞中受损的TCR信号转导。这项研究的结果将提供重要的信息,通过增强细胞免疫力,更好地保护老年人免受肿瘤和感染。当前提案的目标是研究衰老如何影响参与通过其受体(T细胞受体)将刺激从CD 8 + T细胞的外部传递到内部(信号转导)的分子。这项研究的结果将为增强老年人群的免疫反应提供重要信息,从而改善对感染和肿瘤的保护。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Insoo Kang其他文献

Insoo Kang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Insoo Kang', 18)}}的其他基金

Investigating monocyte activation pathways in lupus
研究狼疮中的单核细胞激活途径
  • 批准号:
    10731104
  • 财政年份:
    2023
  • 资助金额:
    $ 13.53万
  • 项目类别:
Studying alterations of T cell immune responses in the 17q12 deletion syndrome
研究 17q12 缺失综合征中 T 细胞免疫反应的变化
  • 批准号:
    10518405
  • 财政年份:
    2021
  • 资助金额:
    $ 13.53万
  • 项目类别:
Studying alterations of T cell immune responses in the 17q12 deletion syndrome
研究 17q12 缺失综合征中 T 细胞免疫反应的变化
  • 批准号:
    10391990
  • 财政年份:
    2021
  • 资助金额:
    $ 13.53万
  • 项目类别:
Studying the impact of altered CD8+ T cell immunity in Alzheimer's disease
研究 CD8 T 细胞免疫改变对阿尔茨海默病的影响
  • 批准号:
    10119925
  • 财政年份:
    2018
  • 资助金额:
    $ 13.53万
  • 项目类别:
Aging and IL-7 mediated CD8+ T cell survival
衰老和 IL-7 介导的 CD8 T 细胞存活
  • 批准号:
    10443824
  • 财政年份:
    2018
  • 资助金额:
    $ 13.53万
  • 项目类别:
Aging and IL-7 mediated CD8+ T cell survival
衰老和 IL-7 介导的 CD8 T 细胞存活
  • 批准号:
    10207438
  • 财政年份:
    2018
  • 资助金额:
    $ 13.53万
  • 项目类别:
Aging and IL-7 mediated CD8+ T cell survival
衰老和 IL-7 介导的 CD8 T 细胞存活
  • 批准号:
    9764233
  • 财政年份:
    2018
  • 资助金额:
    $ 13.53万
  • 项目类别:
The Impact of Aging and HIV Infection on Immunologic and Transcriptomic Signatures of Influenza Vaccine Response
衰老和 HIV 感染对流感疫苗反应的免疫学和转录组学特征的影响
  • 批准号:
    10183118
  • 财政年份:
    2017
  • 资助金额:
    $ 13.53万
  • 项目类别:
Studying the effects of vitamin D on FOXP3 and IL-17 expression in human CD4+ T c
研究维生素 D 对人 CD4 T c 中 FOXP3 和 IL-17 表达的影响
  • 批准号:
    7938575
  • 财政年份:
    2009
  • 资助金额:
    $ 13.53万
  • 项目类别:
Studying the effects of vitamin D on FOXP3 and IL-17 expression in human CD4+ T c
研究维生素 D 对人 CD4 T c 中 FOXP3 和 IL-17 表达的影响
  • 批准号:
    7706357
  • 财政年份:
    2009
  • 资助金额:
    $ 13.53万
  • 项目类别:

相似海外基金

Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
  • 批准号:
    23K08213
  • 财政年份:
    2023
  • 资助金额:
    $ 13.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
  • 批准号:
    2881726
  • 财政年份:
    2023
  • 资助金额:
    $ 13.53万
  • 项目类别:
    Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
  • 批准号:
    10735090
  • 财政年份:
    2023
  • 资助金额:
    $ 13.53万
  • 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
  • 批准号:
    10722146
  • 财政年份:
    2023
  • 资助金额:
    $ 13.53万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 13.53万
  • 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
  • 批准号:
    10935776
  • 财政年份:
    2023
  • 资助金额:
    $ 13.53万
  • 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
  • 批准号:
    10935796
  • 财政年份:
    2023
  • 资助金额:
    $ 13.53万
  • 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
  • 批准号:
    10935775
  • 财政年份:
    2023
  • 资助金额:
    $ 13.53万
  • 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
  • 批准号:
    10735964
  • 财政年份:
    2023
  • 资助金额:
    $ 13.53万
  • 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
  • 批准号:
    10649041
  • 财政年份:
    2023
  • 资助金额:
    $ 13.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了